Analysis of Therapeutic Effect and Prognosis of Radiotherapy for Patients with Esophageal Carcinoma with Supraclavicular Lymph Node Metastasis
-
摘要: 目的 回顾性分析胸段食管癌锁骨上淋巴结转移患者的放疗疗效及其预后影响因素。方法回顾2005年1月—2009年12月经组织学证实的锁骨上淋巴结转移的胸段食管癌病例152例，其中食管原发灶采用放射治疗患者95例，手术治疗57例；食管原发灶治疗后锁骨上淋巴结转移81例，初诊时发现71例；141例患者锁骨上淋巴结行放射治疗，11例患者未行放射治疗。结果全组患者中位随访时间为17.5月（2~77月）。放射治疗后近期疗效评价达CR、PR、NC及PD的分别为52.5%（74/141）、41.8%（59/141）、3.6%（5/141）和2.1%（3/141）。1、2、3年生存率分别为51.3%、26.6%、17.3%。单侧转移与双侧转移患者1、3年生存率分别为54.0%、17.6%和26.7%、13.3%（P=0.033）。转移灶放疗剂量≥60 Gy和<60 Gy患者的1、3年生存率分别为61.5%、21.7%和12.5%、0（P<0.01）。单侧锁骨上区淋巴结转移的患者中，健侧锁骨上区预防照射与未行预防照射患者的1、3年生存率分别为53.7%、12.3%和56.3%、20.6%（P=0.939）。多因素分析示患者的年龄、锁骨上淋巴结转移时间、锁骨上淋巴结转移时食管原发灶控制情况及是否合并内脏转移对预后的影响差异有统计学意义（P=0.007、P=0.009、P=0.008、P<0.01）。结论放射治疗是食管癌锁骨上淋巴结转移的有效治疗手段；锁骨上转移灶放射治疗范围以累及野为宜，剂量60~70 Gy；患者的年龄、锁骨上淋巴结转移时间、食管原发灶的控制情况及是否合并内脏转移对患者的预后有影响。Abstract: Objective To explore the factors affecting the prognosis of radiotherapy for esophageal carcinoma with supraclavicular lymph node metastasis. Methods One hundred and fifty-two esophageal carcinoma patients with supraclavicular lymph node metastases who were admitted to the Fourth Hospital of Hebei Medical University from January 2005 to December 2009 were enrolled.A total of 95 patients with primary tumors received radiotherapy,whereas 57 patients underwent surgery.Eighty one patients were found supraclavicular lymph nodes metastasis after the treatment of primary esophageal carcinoma,and 71 patients were found with metastasis when they were diagnosed.A total of 141 patients with supraclavicular lymph node metastasis received radiotherapy,whereas 11 did not. Results Follow-up time was 2 to 77 months with a median follow-up time of 17.5 months.After radiotherapy for the supraclavicular lymph-node,the rate of CR,PR,NR and PD was 52.5%,41.8%,3.6% and 2.1% respectively.The 1-,2-,3-year overall survival rates were 51.3%,26.6% and 17.3%.The 1-year survival rates for one-side and both sides were 54.0% and 26.7%,and the 3-year survival rates were 17.6% and 13.3% (P=0.033).The 1-,3-year survival rates of patients with supraclavicular lymph nodes metastasis subjected the dose more than 60 Gy were 61.5%,21.7%,and that of less than 60 Gy were 12.5%,0% (P<0.01),respectively.The 1-,3-year survival rates of patients with contralateral supraclavicular prophylactic irradiation were 53.7%,12.3%,and that of without prophylactic irradiation were 56.3%,20.6 % (P=0.939),respectively.Multivariate analysis revealed that age,time of supraclavicular lymphnode metastasis,whether the primary tumors were controlled and visceral metastasis were independent factors for the survivals (P=0.007,0.009,0.008,<0.01). Conclusion The patients of esophageal carcinoma with supraclavicular lymph node metastasis can benefit from radiotherapy.The suitable dose of supraclavicular lymph node was 60～70 Gy.Prophylactic irradiation of contralateral supraclavicular region showed no advantage in prognosis.Age,the time of supraclavicular lymph nodes enlargement with primary esophageal carcinoma,status of the primary tumor and visceral metastasis were independent factors for the survival.
-
Key words:
- Esophageal carcinoma /
- Supraclavicular lymph-node metastasis /
- Radiotherapy /
- Prognosis
-
-
[1] Gu XZ,Yin WB,Liu TF,et al.Radiation oncology[M].Beijing:Beijing Medical University & Peking Union Medical College Press,1993:504-6.[谷铣之,殷蔚伯,刘泰福,等.肿瘤放射治疗学[M].北京：北京医科大学中国协和医科大学联合出版社 ，1993:504-6.] [2] Chen YT,Han JQ,Li JB,et al.Clinical ananlysis of radiotherapy for 1110 patients with esophageal carcinoma[J].Shi Yong Ai Zheng Za Zhi,1994,9(4):250-2.[陈延条,韩俊庆,李建彬,等.1 110例食管癌放射治疗疗效分析[J].实用癌症 杂志,1994,9(4):250-2.] [3] Yang MS,Wu ZX,Wang JJ,et al.Clinical ananlysis of radiotherapy of 1160 patients with esophageal carcinoma for 10 years[J].Zhonghua Fang She Zhong Liu Xue Za Zhi,1992,1(3):174-6.[杨民生,五兆兴,王经建,等.1160例食管癌放射治疗 10年疗效[J].中华放射肿瘤学杂志,1992,1(3):174-6.] [4] Zhu ZF,Zhang G,Lin CH,et al.Combined Modality Therapy for esophageal carcinoma with supraclavicular lymph node metastasis[J].Zhong Liu Fang Zhi Za Zhi,2000,7(3):323.[朱兆峰,张国,林存宏,等.食管癌锁骨上淋巴结转移的综合治疗[J ].肿瘤防治杂志,2000,7(3):323.] [5] Sun LT,Zhao RF,Zhang PH,et al.Surpraclavicular lymph node metastasis from carcinoma of esophagus-analysis of 495 patients[J].Zhongguo Fang She Zhong Liu Xue Za Zhi,1991,5(2):100-2.[孙联亭,赵瑞芬,张佩怀,等.495例食管癌伴锁骨 上淋巴结转移的临床分析[J].中国放射肿瘤学杂志,1991,5(2):100-2.] [6] Li DR,Chen ZJ,Lin ZX,et al.Radiotherapy of neck and mediastinal lymph node metastases after surgieal removal of esophageal cancer[J].Zhongguo Zhong Liu Lin Chuang,1997,24(10):753-5.[李德锐,陈志坚,林志雄,等.食管癌术后颈部和纵 隔淋巴结转移放射治疗的意义[J].中国肿瘤临床,1997,24(10):753-5.] [7] Zhang YH,Tang XJ,Tao RK,et al.Treatment of loco-recurrence after resection of esophageal carcinoma[J].Zhonghua Fang She Zhong Liu Xue Za Zhi,2003,12(2):89-91.[章耀鸿,唐喜军,陶瑞康,等.食管癌术后局部区域复发的治疗[J].中华放射肿瘤学杂志,2003,12(2):89-91.] [8] Shioyama Y,Nakamura K,Ohga S,et al.Radiation therapy for recurrent esophageal cancer after surgery:clinical results and prognostic factors [J].Jpn J Clin Oncol,2007,37(12):918-23. [9] Chen ZJ,Shi YY,Lin ZX,et al.Clinical analysis of radiotherapy for 53 esophageal carcinoma patients with supraclavicular lymph node metastasis[J],Ai Zheng,1995,14(5):388.[陈志坚,史永义,林志雄,等.伴锁骨上淋巴结转移的食 管癌53例放疗分析[J].癌症,1995,14(5):388.] [10] Zhang XM,Lv DP.Radiation therapy for sophageal carcinoma with supraclavicular lymph node metastasis[J].Zhong Liu Fang Zhi Yan Jiu,1996,23(3):173-5.[张新民,吕登平.食管癌锁骨上淋巴结转移的放疗效果[J].肿瘤防治研究,1996,23 (3):173-5.] [11] Guo XM,Mei X,Zhao KL,et al.Clinical analysis of radiotherapy for esophageal carcinoma with supraclavicular lymph node metastasis[J].Zhong Liu Fang Zhi Za Zhi,2005,12(20):1567-70.[郭小毛,梅欣,赵快乐,等.食管癌锁骨上淋巴结 转移放射治疗的疗效和预后因素分析[J].肿瘤防治杂志,2005,12(20):1567-70.]
计量
- 文章访问数: 2772
- HTML全文浏览量: 25
- PDF下载量: 526
下载:
